Impact of Source Control in Patients with Severe Sepsis and Septic Shock

Critical Care Medicine

Volumn 45, Issue 1, 2017, Pages 11-19

  Martínez, María Luisa ^a   Ferrer, Ricard ^b,c   Torrents, Eva ^a   Guillamat Prats, Raquel ^c   Gomà, Gemma ^a   Suárez, David ^a   Álvarez Rocha, Luis ^d   Pozo Laderas, Juan Carlos ^e   Martín Loeches, Ignacio ^f   Levy, Mitchell M ^g   Artigas, Antonio ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF A CORUÑA   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f ST JAMES S HOSPITAL   (Ireland)

^g BROWN UNIVERSITY   (United States)

Author keywords

critical care; infection control; mortality; sepsis; septic shock; severe sepsis

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT; CALCITONIN; VASOCONSTRICTOR AGENT;

ABDOMINAL INFECTION; ADULT; AGE; AGED; ARTICLE; BACTEREMIA; CONTROLLED STUDY; FEMALE; HOSPITAL MORTALITY; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LACTIC ACIDEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTOCOL COMPLIANCE; RESPIRATORY TRACT INFECTION; SEPTIC SHOCK; SOFT TISSUE INFECTION; SOUTHERN EUROPE; TIME TO TREATMENT; ACIDOSIS, LACTIC; BLOOD; CLINICAL TRIAL; INFLAMMATION; LENGTH OF STAY; MORTALITY; MULTICENTER STUDY; SEPSIS; SHOCK, SEPTIC; SOFT TISSUE INFECTIONS; SPAIN; STATISTICS AND NUMERICAL DATA; URINARY TRACT INFECTIONS;

ACIDOSIS, LACTIC; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HOSPITAL MORTALITY; HUMANS; INFLAMMATION; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; SOFT TISSUE INFECTIONS; SPAIN; URINARY TRACT INFECTIONS; VASOCONSTRICTOR AGENTS;

EID: 84986193574     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002011     Document Type: Article

References (30)

1. Vincent JL, Opal SM, Marshall JC, et al: Sepsis defnitions: Time for change. Lancet 2013; 381:774-775
2. Kumar A: An alternate pathophysiologic paradigm of sepsis and septic shock: Implications for optimizing antimicrobial therapy. Virulence 2014; 5:80-97
3. Marshall JC, al Naqbi A: Principles of source control in the management of sepsis. Crit Care Clin 2009; 25:753-68, viii
4. Marshall JC, Maier RV, Jimenez M, et al: Source control in the management of severe sepsis and septic shock: An evidence-based review. Crit Care Med 2004; 32:S513-S526
5. Dellinger R P, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
6. Ferrer R, Artigas A, Levy MM, et al; Edusepsis Study Group: Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008; 299:2294-2303
7. Ferrer R, Martin-Loeches I, Phillips G, et al: Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the frst hour: Results from a guideline-based performance improvement program. Crit Care Med 2014; 42:1749-1755
8. Barochia AV, Cui X, Vitberg D, et al: Bundled care for septic shock: An analysis of clinical trials. Crit Care Med 2010; 38:668-678
9. Levy MM, Fink M P, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Defnitions Conference. Crit Care Med 2003; 31:1250-1256
10. Dellinger R P, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
11. Bloos F, Thomas-Rüddel D, Rüddel H, et al; MEDUSA Study Group: Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: A prospective observational multi-center study. Crit Care 2014; 18:R42
12. Leligdowicz A, Dodek PM, Norena M, et al; Co-operative Antimicrobial Therapy of Septic Shock Database Research Group: Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 2014; 189:1204-1213
13. Garnacho-Montero J, Huici-Moreno MJ, Gutiérrez-Pizarraya A, et al: Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care 2014; 18:R116
14. Wacker C, Prkno A, Brunkhorst FM, et al: Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis. Lancet Infect Dis 2013; 13:426-435
15. Clec'h C, Ferriere F, Karoubi P, et al: Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32:1166-1169
16. Arora S, Singh P, Singh PM, et al: Procalcitonin levels in survivors and nonsurvivors of sepsis: Systematic review and meta-analysis. Shock 2015; 43:212-221
17. Blanco J, Muriel-Bombín A, Sagredo V, et al; Grupo de Estudios y Análisis en Cuidados Intensivos: Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care 2008; 12:R158
18. Koperna T, Schulz F: Relaparotomy in peritonitis: Prognosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000; 24:32-37
19. Marshall JC: Intra-abdominal infections. Microbes Infect 2004; 6:1015-1025
20. Torgersen C, Moser P, Luckner G, et al: Macroscopic postmortem fndings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009; 108:1841-1847
21. Boyer A, Vargas F, Coste F, et al: Infuence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med 2009; 35:847-853
22. Kobayashi L, Konstantinidis A, Shackelford S, et al: Necrotizing soft tissue infections: Delayed surgical treatment is associated with increased number of surgical debridements and morbidity. J Trauma 2011; 71:1400-1405
23. Wong CH, Chang HC, Pasupathy S, et al: Necrotizing fasciitis: Clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85-A:1454-1460
24. Moss RL, Musemeche CA, Kosloske AM: Necrotizing fasciitis in children: Prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996; 31:1142-1146
25. Tridente A, Clarke GM, Walden A, et al; GenOSept Investigators: Patients with faecal peritonitis admitted to European intensive care units: An epidemiological survey of the GenOSept cohort. Intensive Care Med 2014; 40:202-210
26. Mier J, León EL, Castillo A, et al: Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997; 173:71-75
27. Hartwig W, Maksan SM, Foitzik T, et al: Reduction in mortality with delayed surgical therapy of severe pancreatitis. J Gastrointest Surg 2002; 6:481-487
28. Opal SM, Dellinger R P, Vincent JL, et al: The next generation of sepsis clinical trial designs: What is next after the demise of recombinant human activated protein C?&z.ast;. Crit Care Med 2014; 42:1714-1721
29. Bosshardt TL, Henderson VJ, Organ CH Jr: Necrotizing soft-tissue infections. Arch Surg 1996; 131:846-852
30. Mulier S, Penninckx F, Verwaest C, et al: Factors affecting mortality in generalized postoperative peritonitis: Multivariate analysis in 96 patients. World J Surg 2003; 27:379-384